Stoke Therapeutics, Inc. (STOK) Financials

STOK Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 239.9 million 66.9 million
2023-06-30 256.9 million 66.7 million
2023-03-31 281.8 million 68.0 million
2022-12-31 256.1 million 71.2 million

STOK Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -17.6 million 6.6 million
2023-06-30 -22.6 million 6.8 million
2023-03-31 -21.5 million 5.9 million
2022-12-31 -22.8 million 5.8 million

STOK Net Income

No data available :(

STOK Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 214.7 million - 2.5 million
2023-06-30 231.4 million - 2.5 million
2023-03-31 253.7 million - 2.4 million
2022-12-31 229.6 million - 2.4 million

STOK Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 44.3 million
2023-06-30 44.2 million
2023-03-31 42.5 million
2022-12-31 39.4 million

STOK Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 383000 20.3 million 10.3 million -
2023-06-30 839000 20.6 million 10.2 million -
2023-03-31 165000 19.6 million 10.2 million -
2022-12-31 409000 21.1 million 9.4 million -

STOK Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 3.3 million 1.2 million
2023-06-30 -2.5 million 1.2 million
2023-03-31 5.2 million 1.1 million
2022-12-31 3.3 million 1.2 million

STOK

Price: $11.69

52 week price:
3.35
16.40

Earnings Per Share: -2.38 USD

P/E Ratio: -1.81

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 66686

Market Capitalization: 558.8 million

Links: